Close

Pacira Pharma (PCRX): Conference Checks Hint At Positive Inflection For Exparel - Mizuho

September 25, 2017 6:18 AM EDT Send to a Friend
Mizuho Securities analyst, Irina Koffler, reiterated her Buy rating on shares of Pacira Pharmaceuticals (NASDAQ: PCRX) after attending the NYSORA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login